Earnings Per Share, Basic of SpringWorks Therapeutics, Inc. from 31 Dec 2020 to 31 Mar 2025
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
SpringWorks Therapeutics, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2020 to 31 Mar 2025.
- SpringWorks Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 31 Mar 2025 was -1.11, a 5.9% increase year-over-year.
- SpringWorks Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 31 Mar 2025 was -3, a 34% increase year-over-year.
- SpringWorks Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -3.48, a 32% increase from 2023.
- SpringWorks Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -5.15, a 1.2% increase from 2022.
- SpringWorks Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -5.21, a 45% decline from 2021.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
SpringWorks Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2025 | -3 | -1.11 | +0.07 | +5.9% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 09 May 2025 | 2025 | Q1 |
| Q4 2024 | -3 | -1.04 | +0.41 | +28% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 20 Feb 2025 | 2024 | FY |
| Q3 2024 | -4 | -0.72 | +0.55 | +43% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 12 Nov 2024 | 2024 | Q3 |
| Q2 2024 | -4 | -0.54 | +0.71 | +57% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 07 Aug 2024 | 2024 | Q2 |
| Q1 2024 | -5 | -1.18 | 0 | 0% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 09 May 2025 | 2025 | Q1 |
| Q4 2023 | -5 | -1.45 | 01 Oct 2023 | 31 Dec 2023 | 10-K | 20 Feb 2025 | 2024 | FY | ||
| Q3 2023 | -1.27 | +0.1 | +7.3% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 12 Nov 2024 | 2024 | Q3 | |
| Q2 2023 | -1.25 | +0.16 | +11% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 07 Aug 2024 | 2024 | Q2 | |
| Q1 2023 | -1.18 | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 02 May 2024 | 2024 | Q1 | |||
| Q3 2022 | -1.37 | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 02 Nov 2023 | 2023 | Q3 | |||
| Q2 2022 | -1.41 | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
SpringWorks Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | -3.48 | +1.67 | +32% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 20 Feb 2025 | 2024 | FY |
| 2023 | -5.15 | +0.06 | +1.2% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 20 Feb 2025 | 2024 | FY |
| 2022 | -5.21 | -1.62 | -45% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 20 Feb 2025 | 2024 | FY |
| 2021 | -3.59 | -2.54 | -242% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 27 Feb 2024 | 2023 | FY |
| 2020 | -1.05 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 28 Feb 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.